MAPK1 and cancer: In addition, it can also activate multiple pro-tumorigenic signaling pathways such as NF-κB, TGF-β, JAK2-STAT1 and PI3K/Akt/ERK or activate oncogenes and inhibit tumor suppressors to enhance cancer progression [43–47].